Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies (Volume 1) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 1) - Image 1

£112.35

Academic Press Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies (Volume 1) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 1)

Name: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies (Volume 1) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 1)
Brand: Academic Press
Price: 112.35 GBP
Availability: InStock

Biological Science

It has never been this cheap. We have no record of a lower price.

£112 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 60 days • 60 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 60 days • 1 price levels

Days at Price

Price Analysis

Most common price: £112 (60 days, 100.0%)

Price range: £112 - £112

Price levels: 1 different prices over 60 days

Description

Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs and other sensitizers. The book gives insights into the landscape of anti-EGFR based cancer treatments, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. It offers pertinent science information on strategies used for the rational design and discovery of novel sensitizing agents, and in addition, translational studies involving pre-clinical and clinical design. This book is an indispensable resource for cancer researchers, medicinal chemists and other biomedical scientists. Finally, the book covers basic science strategies used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology, including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance. Review A unique source on the molecular structures for all novel anticancer drugs that includes strategies to overcome resistance of anti-EGFR antibodies About the Author Dr. Shi Hu received an MD and a PhD in tumor immunology from Second Military Medical University, Shanghai, China. Since 2015, Dr. Hu leads a research laboratory in the Department of Biophysics, at second military medical university with a faculty position. His laboratory is interested in cancer therapeutics and antibody engineering, primarily development of novel sensitizers for antibody-based therapies (e.g., Anti-ERBB antibodies). Dr. Hu’s research is currently supported by the National Natural Science Foundation of China and Military Medicine Special grant of Second Military Medical University.

Product Specifications

Brand: Academic Press
Format: hardcover
ASIN: 0128215844
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biological Science
Domain: Amazon UK
Release Date: 21 November 2022
Listed Since: 30 October 2019

Barcode

No barcode data available

Academic Press Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies (Volume 1) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 1)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

FIGHTING LUNG CANCER THROUGH THE HER FA (Cancer Etiology, Diagnosis and Treatments)

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Handbook of Targeted Cancer Therapy and Immunotherapy

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Holland-Frei Cancer Medicine - Volume 1 and 2

Drug Resistance in Cancer Cells

Advances in Cancer Research: 77: Volume 77

Abeloff's Clinical Oncology

Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC (Volume 19) (Cancer Sensitizing Agents for Chemotherapy, Volume 19)

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Cancer Chemotherapy: Basic Science to the Clinic

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Springer International Manual of Oncology Practice - iMOP

Evidence–Based Oncology (Evidence–Based Medicine)

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Humana Combination Cancer Therapy: Modulators and Potentiators

Targeted Therapies in Oncology